LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call tomorrow, March 4, 2010, to provide a strategic update on its progesterone business. Frank C. Condella, Jr., interim chief executive officer, and Lawrence Gyenes, senior vice president, chief financial officer and treasurer of Columbia Laboratories, will host the call.
